| P2093 | author name string | Zhigang Tian | |
| | Bin Gao | |
| | Feng Hong | |
| | Svetlana Radaeva | |
| | Hong-na Pan | |
| | Richard Veech | |
| P2860 | cites work | Massive liver growth in mice induced by systemic interleukin 6 administration. | Q51835027 |
| | Liver failure and defective hepatocyte regeneration in interleukin-6-deficient mice. | Q52522262 |
| | Failure of regeneration of the steatotic rat liver: disruption at two different levels in the regeneration pathway. | Q52537460 |
| | Lack of gp130 expression in hepatocytes promotes liver injury1 1K.L.S. and T.W. contributed equally to this work | Q57339931 |
| | IL-6: a magic potion for liver transplantation? | Q57547025 |
| | Intracerebroventricular interleukin-6 treatment decreases body fat in rats | Q59649473 |
| | Combined interleukin 6 and soluble interleukin 6 receptor accelerates murine liver regeneration | Q62658884 |
| | Ischemic preconditioning protects the mouse liver by inhibition of apoptosis through a caspase-dependent pathway | Q73114530 |
| | Mechanisms of ischemic injury are different in the steatotic and normal rat liver | Q73229693 |
| | Increased monocyte nuclear factor-kappaB activation and tumor necrosis factor production in alcoholic hepatitis | Q73792877 |
| | Interleukin-6 protects liver against warm ischemia/reperfusion injury and promotes hepatocyte proliferation in the rodent | Q73939856 |
| | A new and simple technique of total hepatic ischemia in the mouse | Q74725233 |
| | Peroxisomal and mitochondrial fatty acid beta-oxidation in mice nullizygous for both peroxisome proliferator-activated receptor alpha and peroxisomal fatty acyl-CoA oxidase. Genotype correlation with fatty liver phenotype | Q77926979 |
| | Ischemia impairs liver regeneration after major tissue loss in rodents: protective effects of interleukin-6 | Q78045269 |
| | Essential role of tumor necrosis factor alpha in alcohol-induced liver injury in mice | Q24170238 |
| | Peroxisome proliferator-activated receptor alpha mediates the adaptive response to fasting | Q24563197 |
| | In vitro interleukin-6 treatment prevents mortality associated with fatty liver transplants in rats | Q30960436 |
| | Cytokines in alcoholic liver disease | Q33697078 |
| | Fatty liver in liver transplantation and surgery | Q34215124 |
| | Clinical features and natural history of nonalcoholic steatosis syndromes | Q34215131 |
| | Nonalcoholic steatosis and steatohepatitis. III. Peroxisomal beta-oxidation, PPAR alpha, and steatohepatitis | Q34436747 |
| | Update on nonalcoholic fatty liver disease | Q34548921 |
| | Opposing roles of STAT1 and STAT3 in T cell-mediated hepatitis: regulation by SOCS. | Q34826141 |
| | AGA technical review on nonalcoholic fatty liver disease | Q34982453 |
| | Non-alcoholic fatty liver disease: an overview | Q35009628 |
| | Molecular mechanisms of hepatic ischemia-reperfusion injury and preconditioning | Q35028609 |
| | Apoptosis versus oncotic necrosis in hepatic ischemia/reperfusion injury | Q35546843 |
| | STAT-3 overexpression and p21 up-regulation accompany impaired regeneration of fatty livers | Q35747457 |
| | Interferon-alpha activates multiple STAT signals and down-regulates c-Met in primary human hepatocytes | Q38290942 |
| | Probiotics and antibodies to TNF inhibit inflammatory activity and improve nonalcoholic fatty liver disease | Q38358419 |
| | Peroxisome proliferator-activated receptor alpha (PPARalpha) agonist treatment reverses PPARalpha dysfunction and abnormalities in hepatic lipid metabolism in ethanol-fed mice | Q40641820 |
| | Seven hundred forty-seven hepatectomies in the 1990s: an update to evaluate the actual risk of liver resection | Q40757028 |
| | Ischemic preconditioning increases the tolerance of Fatty liver to hepatic ischemia-reperfusion injury in the rat. | Q42114330 |
| | Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity | Q43031928 |
| | Tumor necrosis factor alpha, but not Fas, mediates hepatocellular apoptosis in the murine ischemic liver | Q43534255 |
| | Interleukin-6 protects against Fas-mediated death by establishing a critical level of anti-apoptotic hepatic proteins FLIP, Bcl-2, and Bcl-xL. | Q43604824 |
| | Elevated interleukin-6 during ethanol consumption acts as a potential endogenous protective cytokine against ethanol-induced apoptosis in the liver: involvement of induction of Bcl-2 and Bcl-x(L) proteins | Q43854595 |
| | Transgenic mice overexpressing human Bcl-2 are resistant to hepatic ischemia and reperfusion | Q43878357 |
| | Low-dose TNF-alpha protects against hepatic ischemia-reperfusion injury in mice: implications for preconditioning | Q44261195 |
| | Ischemic preconditioning protects the steatotic mouse liver against reperfusion injury: an ATP dependent mechanism | Q44487614 |
| | Central role of PPARalpha-dependent hepatic lipid turnover in dietary steatohepatitis in mice | Q44493750 |
| | Interleukin 6/gp130-dependent pathways are protective during chronic liver diseases | Q44493772 |
| | Cytokines and NASH: a pilot study of the effects of lifestyle modification and vitamin E. | Q44527604 |
| | Dual role of tumor necrosis factor-alpha in hepatic ischemia-reperfusion injury: studies in tumor necrosis factor-alpha gene knockout mice | Q44759287 |
| | Administration of the potent PPARalpha agonist, Wy-14,643, reverses nutritional fibrosis and steatohepatitis in mice | Q44880254 |
| | Interleukin 6 is important for survival after partial hepatectomy in mice | Q45233229 |
| | Interleukin-6 stimulates hepatic triglyceride secretion in rats | Q46353326 |
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | steatosis | Q1365091 |
| | fatty liver disease | Q6058862 |
| P304 | page(s) | 933-941 | |
| P577 | publication date | 2004-10-01 | |
| P1433 | published in | Hepatology | Q15724398 |
| P1476 | title | Interleukin 6 alleviates hepatic steatosis and ischemia/reperfusion injury in mice with fatty liver disease | |
| P478 | volume | 40 | |